AI assistant
Inogen Inc — Director's Dealing 2018
Nov 13, 2018
33625_dirs_2018-11-13_837090b7-086d-40bd-88c4-f073395b50aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2018-11-08
Reporting Person: McFarland Loren L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-08 | Common Stock | M | 2000 | $16.62 | Acquired | 2989 | Direct |
| 2018-11-08 | Common Stock | S | 2000 | $155.24 | Disposed | 989 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-08 | Stock Option (Right to Buy) | $16.62 | M | 2000 | Disposed | 2021-03-31 | Common Stock (2000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2017.
F2: Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $154.75 to $155.66 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Subject to the reporting person's continuing service, 1/24th of the total shares subject to the option shall vest every month after April 1, 2014.